Description

Pridinol is a synthetic anticholinergic and antispasmodic agent with the CAS registry number 511-45-5. This compound is valued for its ability to act as a skeletal muscle relaxant by blocking muscarinic acetylcholine receptors and interfering with polysynaptic reflexes. It is primarily required by the pharmaceutical industry for the formulation of medications targeting conditions such as muscle spasticity, Parkinson's disease, and drug-induced extrapyramidal symptoms.

Application

• Pharmaceutical Active Ingredient (API): Core component in prescription medications for muscle relaxation.
• Treatment of Muscle Spasticity: Used in formulations to alleviate symptoms associated with multiple sclerosis, cerebral palsy, and spinal cord injuries.
• Parkinson's Disease Therapy: Employed as an adjunctive treatment to manage muscular rigidity and tremors.
• Management of Drug-Induced Dystonias: Addresses extrapyramidal side effects caused by antipsychotic drugs.
• Veterinary Medicine: Applied in animal health for similar antispasmodic indications.
• Research & Development: Serves as a reference standard and a key intermediate in pharmacological studies targeting the cholinergic system.

Basic Information

Product Name	Pridinol
CAS No.	511-45-5
Molecular Formula	C20H25NO
Molecular Weight	295.42 g/mol
Synonyms	α,α-Diphenyl-1-piperidinepropanol; 3-(Diphenylhydroxymethyl)-1-methylpiperidine; 1-Methyl-3,3-diphenyl-3-(1-piperidyl)-1-propanol; Pridinolum; Pridinoli; Pridinol Hydrochloride (salt form); Loxapine related compound B (in some contexts); AKOS BBS-00004375
EINECS	208-125-8

Quality Control

Our Pridinol is manufactured under strict quality management systems to ensure high purity and batch-to-batch consistency, suitable for pharmaceutical applications. We provide comprehensive analytical documentation, including a Certificate of Analysis (COA) that details identity, purity, and impurity profiles as per in-house specifications. While not compendial, our quality standards are aligned with the rigorous principles of GMP (Good Manufacturing Practice) for active pharmaceutical ingredients.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.